FDA panel overwhelmingly votes against experimental ALS treatment pushed by patients
CBSN
Federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrig's disease at a Wednesday meeting prompted by years of patient efforts seeking access to the unproven therapy.
The panel of Food and Drug Administration experts voted 17-1 that drugmaker Brainstorm's stem cell-based treatment has not been shown effective for patients with the fatal, muscle-wasting disease known as ALS, or amyotrophic lateral sclerosis. One panel member abstained from voting.
While the FDA is not bound by the vote, it largely aligns with the agency's own strikingly negative review released earlier this week, in which staff scientists described Brainstorm's application as "scientifically incomplete" and "grossly deficient."

The race to fill the seat of retiring Illinois Sen. Dick Durbin has been heating up in the days leading up to Tuesday's 2026 Democratic primary and could set the tone for other midterm primaries on issues like President Trump's deportation policies and outside spending. And another factor in the race is Gov. JB Pritzker's attempt at powerbrokering: he's given his endorsement and millions in campaign funds to his lieutenant governor, Julianna Stratton. In:

A man who was accused of planting pipe bombs outside the Republican National Committee and Democratic National Committee headquarters on the eve of the Jan. 6 attack in 2021 is asking a judge to dismiss the criminal charges against him, arguing he is covered by President Trump's sweeping pardons of alleged Jan. 6 rioters.

The Cuban government is planning to allow Cuban nationals who live abroad — including in the U.S. — to invest in companies on the island, a top government official told NBC News in an interview that aired Monday, as the country faces economic collapse and immense pressure from the Trump administration.










